Clinical Trials Browser

Recruiting × Carcinoma, Non-Small-Cell Lung × Idarubicin × Clear all

NCT06492421 2024-07-09

Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms